Resynchronization-Defibrillation for Ambulatory Heart Failure Trial - RAFT


Earlier trials have established the superiority of cardiac resynchronization therapy (CRT)-D over implantable cardioverter-defibrillator (ICD) alone in patients with severely symptomatic chronic heart failure (CHF) (New York Heart Association [NYHA] class III or IV), left ventricular (LV) systolic dysfunction, and wide QRS complex.

In addition, another trial (MADIT-CRT) noted a reduction in death or CHF hospitalization with CRT-D, as compared with ICD alone in patients with NYHA ...